These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 31286981)

  • 1. Genetic and molecular biology of breast cancer among Iranian patients.
    Moghbeli M
    J Transl Med; 2019 Jul; 17(1):218. PubMed ID: 31286981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and molecular biology of bladder cancer among Iranian patients.
    Mojarrad M; Moghbeli M
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1233. PubMed ID: 32253828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of blood malignancies among Iranian population: an overview.
    Ghayour-Mobarhan M; Zangouei AS; Hosseinirad SM; Mojarrad M; Moghbeli M
    Diagn Pathol; 2020 May; 15(1):44. PubMed ID: 32375828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and molecular origins of colorectal Cancer among the Iranians: an update.
    Abbaszadegan MR; Moghbeli M
    Diagn Pathol; 2018 Dec; 13(1):97. PubMed ID: 30579343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and molecular bases of esophageal Cancer among Iranians: an update.
    Abbaszadegan MR; Keyvani V; Moghbeli M
    Diagn Pathol; 2019 Aug; 14(1):97. PubMed ID: 31470870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and molecular determinants of prostate cancer among Iranian patients: An update.
    Ghayour-Mobarhan M; Ferns GA; Moghbeli M
    Crit Rev Clin Lab Sci; 2020 Jan; 57(1):37-53. PubMed ID: 31895010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Nucleotide Polymorphisms as the Efficient Prognostic Markers in Breast Cancer.
    Alimardani M; Moghbeli M; Rastgar-Moghadam A; Shandiz FH; Abbaszadegan MR
    Curr Cancer Drug Targets; 2021; 21(9):768-793. PubMed ID: 34036920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.
    Moghbeli M
    Cell Mol Neurobiol; 2020 Jan; 40(1):65-85. PubMed ID: 31482432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of Methylenetetrahydrofolate Reductase C677T Polymorphism and Human Papilloma Virus Genotypes in Iranian Breast Cancer.
    Rezaei H; Rassi H; Mansur FN
    Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):124-128. PubMed ID: 28537481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Biology In Young Women With Breast Cancer: From Tumor Gene Expression To DNA Mutations.
    Gómez-Flores-Ramos L; Castro-Sánchez A; Peña-Curiel O; Mohar-Betancourt A
    Rev Invest Clin; 2017; 69(4):181-192. PubMed ID: 28776603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between hTERT polymorphisms and the risk of breast cancer in a sample of Southeast Iranian population.
    Hashemi M; Amininia S; Ebrahimi M; Hashemi SM; Taheri M; Ghavami S
    BMC Res Notes; 2014 Dec; 7():895. PubMed ID: 25491902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and molecular biology of male infertility among Iranian population: an update.
    Mojarrad M; Saburi E; Golshan A; Moghbeli M
    Am J Transl Res; 2021; 13(6):5767-5785. PubMed ID: 34306325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation as a critical epigenetic process during tumor progressions among Iranian population: an overview.
    Akhlaghipour I; Bina AR; Abbaszadegan MR; Moghbeli M
    Genes Environ; 2021 Apr; 43(1):14. PubMed ID: 33883026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
    Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
    BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of PARP1 rs4653734, rs907187 and rs1136410 variants with breast cancer risk among Iranian women.
    Ramezani S; Sharafshah A; Mirzanejad L; Hadavi M
    Gene; 2019 Sep; 712():143954. PubMed ID: 31288058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel insights into breast cancer progression and metastasis: A multidisciplinary opportunity to transition from biology to clinical oncology.
    Scimeca M; Urbano N; Bonfiglio R; Duggento A; Toschi N; Schillaci O; Bonanno E
    Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):138-148. PubMed ID: 31348975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine.
    Aleskandarany MA; Vandenberghe ME; Marchiò C; Ellis IO; Sapino A; Rakha EA
    Pathobiology; 2018; 85(1-2):23-34. PubMed ID: 29428954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer.
    Madrid-Paredes A; Cañadas-Garre M; Sánchez-Pozo A; Calleja-Hernández MÁ
    Pharmacogenomics; 2015; 16(12):1411-26. PubMed ID: 26257318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronological changes and trend of breast cancer clinics and pathology among Iranian women during 22 years from the largest breast cancer registry in Iran.
    Tahmasebi S; Tajali M; Akrami M; Arasteh P; Zangouri V; Nobandegani AS; Hosseini SM; Safari A; Talei A
    World J Surg Oncol; 2019 Dec; 17(1):207. PubMed ID: 31801561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.